30.03.2015 Alphaform AG  DE0005487953

DGAP-News: Alphaform AG: Alphaform presents final figures for the 2014 financial year


 
DGAP-News: Alphaform AG / Key word(s): Final Results Alphaform AG: Alphaform presents final figures for the 2014 financial year 30.03.2015 / 11:33 --------------------------------------------------------------------- Press Release Alphaform presents final figures for the 2014 financial year - Revenue rises to EUR29.1 million in 2014 - EBITDA improves to EUR-1.3 million - For 2015, Alphaform anticipates another double-digit increase in revenue and a significant improvement in earnings Feldkirchen, 30 March 2015. Alphaform AG, Europe's leading industrial 3D printing service provider, published its 2014 annual report today. It does not contain any significant changes in comparison to the preliminary figures published on 26 February 2015. According to the annual report, revenue in the last financial year rose by 12.4% to EUR29.1 million. EBITDA improved by EUR2.2 million to EUR-1.3 million and the consolidated net loss improved by EUR3.0 million to EUR-3.2 million. The year 2014 was influenced by extensive restructuring as part of the Alphaform Excellence programme. This programme, launched in the first quarter of 2014, is based on five pillars: in addition to improving processes and structures in the three business segments, it also includes strengthening sales and the corporate culture. For four of the five pillars, the programme took effect as planned during 2014 and made a key contribution to the significant improvement in the earnings situation in two of the three business segments. For the third business segment, Additive Manufacturing Plastic at the Feldkirchen location, the Management Board additionally established an 11-point plan in autumn 2014 in light of continuing challenges. This plan will now be implemented in 2015 as systematically as the Excellence programme itself. Alphaform anticipates further improvement in revenue and earnings in 2015 For 2015 as a whole, Alphaform plans a double-digit increase in revenue and another significant improvement in earnings. After investments totalling EUR3.0 million in 2014, the company will make substantial investments in machinery and in ongoing strengthening of sales in 2015 as well. Financing is ensured by the fact that cash and cash equivalents doubled year-on-year to EUR2.4 million as at 31 December 2014, as well as by the most recent capital increase on 16 March 2015 involving new investors with a long-term focus. At the same time, Alphaform is working on the demanding process of obtaining further certification in order to establish itself as a series manufacturer for promising sectors such as the aerospace industry. Alphaform is already certified for medical technology and expects to receive an order for 3D printing of medical technology implants for the first time in the current year. Alphaform CEO Dr Hanns-Dieter Aberle explains: "We are entering a new era. More and more applications for 3D printing are emerging in more and more sectors - and Alphaform is among the pioneers." Alphaform therefore intends to participate at an above-average rate in the continued double-digit market growth in the years ahead that is forecast by market researchers. In this context, the company is also focussing on linking state-of-the-art manufacturing methods with digital approaches. CEO Aberle comments: "Alphaform is already living in the age of Industry 4.0. We intend to build on this lead in 2015 and beyond." The full annual report is available for download at http://www.alphaform.de/de/investor-relations/news/finanzberichte/.
Key figures in EUR million          2014            2013            Change
Revenue                             29.1            25.9            +12.4%
EBITDA                              -1.3            -3.5            -62.8%
Operating result                    -2.6            -5.8            -55.2%
Consolidated net profit/loss        -3.2            -6.2            -48.4%
Earnings per share                  EUR-0.42        EUR-1.16        -63.8%
Equity*                             9.6             6.6             +45.5%
Liquidity*                          2.4             1.2             +100%
Total assets*                       20.0            15.8            +26.6%
Employees*                          249             227             +9.7%


* as at 31 December About Alphaform Founded in 1996 and headquartered in Feldkirchen near Munich, Alphaform AG is a leading European handler for the renovation of industrial development and production with innovative 3D printing and rapid technologies. As a service provider, Alphaform guides its clients from product development through to product manufacture; it assists them in introducing and utilising innovations and delivers expertise, engineering knowledge, prototypes, individual parts, small-scale series, series and project management. Among others, Alphaform today serves the premium manufacturers of the automotive industry, mechanical, plant and automotive engineering, the aerospace industry, tool making and medical technology. Its particular areas of expertise include complex assembly, lightweight construction and orthopaedic implants and instruments. It has subsidiaries in Germany, Finland, Sweden and the UK. Alphaform's shares are listed in the Prime Standard segment of the Frankfurt stock exchange (code: ATF; securities code number (WKN): 548 795). Contact: Dr. Hanns-Dieter Aberle, CEO Thomas Kresser, CFO Alphaform AG Alphaform AG Kapellenstraße 10 Kapellenstraße 10 85622 Feldkirchen 85622 Feldkirchen Tel.: +49 89 905002 35 Tel.: +49 89 905002 35 Fax: +49 89 905002 1035 Fax: +49 89 905002 1035 e-mail: [email protected] e-mail: [email protected] Internet: www.alphaform.de Internet: www.alphaform.de Disclaimer This press release/ad-hoc disclosure is not an offer document and does not constitute an offer of shares of Alphaform AG ("Company") nor an invitation to an offer to buy or subscribe for shares or securities of the Company but is provided for information only. This press release/ad-hoc disclosure may contain forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. Forward-looking statements may include, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation and supply and demand. The Company has based these forward-looking statements on its views and assumptions with respect to future events and financial performance. Actual financial performance could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse than anticipated. Given these uncertainties, persons should not put undue reliance on any forward-looking statements. The information contained in this presentation is subject to change without notice and the Company does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable laws and regulations. Important notice to persons in the United States of America All information in this press release/ad-hoc disclosure is being made available in the United States of America only to persons believed by the Company to be capable of understanding and evaluating the risks of a transaction. No shares or other securities of the Company have been registered or otherwise qualify for a public sale or resale under federal or state laws in the United States of America. Each recipient of information doing business in or organized under any federal or state laws in the United States of America or in areas subject to its jurisdiction represents that it is an "accredited investor" as defined by Rule 501 or Regulation D under the Securities Act of 1993 ("the Act") and acknowledges that none of the shares in the Company will be registered under the Act and cannot be resold in the absence of such registration or the availability of an exemption there from. The shares in the Company have not been approved or disapproved by the United States Securities and Exchange Commission, any state securities commission or other regulatory authority, nor have any of these authorities passed judgment upon or endorsed the merits of an investment in the shares of the Company or the accuracy or adequacy of this presentation. Any representation to the contrary is a criminal offence. Important notice to persons in the United Kingdom All information in this press release/ad-hoc disclosure is being made available to the recipients on the basis that they are persons covered by Article 11(3) of the Financial Services Act 1986 (Investment Advertisements) (Exemptions) Order 1996. By accepting this document the recipient warrants and represents that he or it is such a person. --------------------------------------------------------------------- 30.03.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Alphaform AG Kapellenstraße 10 85622 Feldkirchen Germany Phone: +49 (0)89 905002 - 0 Fax: +49 (0)89 905002 - 90 E-mail: [email protected] Internet: www.alphaform.de ISIN: DE0005487953 WKN: 548795 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 339161 30.03.2015


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA1,2 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA-Marge3 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT1,4 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT-Marge5 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Jahresüberschuss1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Netto-Marge6 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Cashflow1,7 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer:

INVESTOR-INFORMATIONEN
©boersengefluester.de
WKN Kurs in € Einschätzung Börsenwert in Mio. €
0,000 0,00
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 0,00
KBV KCV KUV EV/EBITDA
0,00 0,00 0,00 0,00
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,00% 0,00% 0,00% 0,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Alphaform AG  ISIN: DE0005487953 können Sie bei EQS abrufen


Kunststoffe , 548795